Carlos Munoz-Zuluaga

9PUBLICATIONS
16CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersComputational physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 08, 2021
Mobile Applications: Breaking Barriers to Early Breast and Cervical Cancer Detection in Underserved Communities.

Carlos A Munoz-Zuluaga, José David Gallo-Pérez, Andrés Pérez-Bustos

|Dec 31, 2020
Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).

Carlos A Munoz-Zuluaga, Armando Sardi, Michelle Sittig

|Dec 28, 2020
Germline and somatic genetic alterations in two first-degree relatives with appendiceal low-grade mucinous carcinoma peritonei.

Mary Caitlin King, Carlos Munoz-Zuluaga, Panayotis Ledakis

|Jul 25, 2020
Defining "Complete Cytoreduction" After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis.

Carlos A Munoz-Zuluaga, Mary C King, Victor S Diaz-Sarmiento

|Dec 08, 2018
Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Carlos Munoz-Zuluaga, Armando Sardi, Mary Caitlin King

|Jun 09, 2018
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma.

Armando Sardi, Carlos A Muñoz-Zuluaga, Michelle Sittig

Pageof 2

Frequent Collaborators

8 joint publications

Armando Sardi

4 joint publications

Mary Caitlin King

4 joint publications

Michelle Sittig

4 joint publications

Vadim Gushchin